Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 8 | 2023 | 896 | 1.470 |
Why?
|
| Status Epilepticus | 2 | 2024 | 154 | 1.190 |
Why?
|
| Tuberous Sclerosis | 3 | 2024 | 124 | 1.160 |
Why?
|
| Drug Resistant Epilepsy | 4 | 2023 | 222 | 1.070 |
Why?
|
| Electroencephalography | 4 | 2024 | 897 | 0.810 |
Why?
|
| Anticonvulsants | 2 | 2024 | 393 | 0.560 |
Why?
|
| Propylene Glycols | 1 | 2015 | 19 | 0.480 |
Why?
|
| Phenylcarbamates | 1 | 2015 | 16 | 0.480 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 2 | 2025 | 8 | 0.480 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2015 | 41 | 0.470 |
Why?
|
| Ataxia | 2 | 2023 | 177 | 0.470 |
Why?
|
| Ocular Motility Disorders | 1 | 2015 | 38 | 0.460 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 79 | 0.460 |
Why?
|
| Intellectual Disability | 3 | 2022 | 1091 | 0.460 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2025 | 545 | 0.410 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2012 | 6 | 0.400 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 187 | 0.400 |
Why?
|
| Developmental Disabilities | 3 | 2025 | 742 | 0.390 |
Why?
|
| Microcephaly | 1 | 2015 | 354 | 0.380 |
Why?
|
| Homicide | 1 | 2012 | 35 | 0.380 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2012 | 45 | 0.380 |
Why?
|
| Epilepsy, Generalized | 2 | 2023 | 65 | 0.380 |
Why?
|
| Laser Therapy | 2 | 2023 | 227 | 0.340 |
Why?
|
| Seizures | 7 | 2023 | 890 | 0.330 |
Why?
|
| Suicide | 1 | 2012 | 204 | 0.320 |
Why?
|
| Child Abuse | 1 | 2012 | 203 | 0.320 |
Why?
|
| Genetic Testing | 1 | 2013 | 1099 | 0.250 |
Why?
|
| Vigabatrin | 1 | 2024 | 17 | 0.220 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2023 | 13 | 0.210 |
Why?
|
| Myoclonus | 1 | 2023 | 33 | 0.210 |
Why?
|
| Hemispherectomy | 1 | 2023 | 26 | 0.200 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2022 | 7 | 0.200 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2022 | 9 | 0.200 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 94 | 0.190 |
Why?
|
| Adaptation, Psychological | 1 | 2025 | 449 | 0.190 |
Why?
|
| Dystonia | 1 | 2023 | 173 | 0.180 |
Why?
|
| Child | 10 | 2025 | 25890 | 0.170 |
Why?
|
| Infant | 5 | 2025 | 13240 | 0.160 |
Why?
|
| Child, Preschool | 8 | 2025 | 14884 | 0.160 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 19 | 0.160 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 428 | 0.160 |
Why?
|
| Brain Waves | 1 | 2019 | 48 | 0.150 |
Why?
|
| Treatment Outcome | 5 | 2023 | 13074 | 0.150 |
Why?
|
| Humans | 17 | 2025 | 134156 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 286 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8623 | 0.130 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 482 | 0.120 |
Why?
|
| Male | 9 | 2025 | 66127 | 0.120 |
Why?
|
| Female | 10 | 2025 | 71928 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3857 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 2266 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 337 | 0.100 |
Why?
|
| Newspapers as Topic | 1 | 2012 | 6 | 0.100 |
Why?
|
| Child of Impaired Parents | 1 | 2012 | 18 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17540 | 0.100 |
Why?
|
| Eye Movements | 1 | 2012 | 79 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2014 | 539 | 0.090 |
Why?
|
| Gain of Function Mutation | 2 | 2023 | 116 | 0.090 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 82 | 0.090 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 154 | 0.090 |
Why?
|
| Phenotype | 2 | 2025 | 4598 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 868 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3754 | 0.080 |
Why?
|
| Adolescent | 5 | 2025 | 20624 | 0.080 |
Why?
|
| Cause of Death | 1 | 2012 | 507 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2014 | 840 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 1387 | 0.070 |
Why?
|
| Mutation | 3 | 2025 | 6338 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2012 | 887 | 0.060 |
Why?
|
| Incidence | 1 | 2012 | 3416 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2025 | 300 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 117 | 0.050 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 6 | 0.050 |
Why?
|
| 4-Aminopyridine | 1 | 2023 | 35 | 0.050 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2023 | 42 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2025 | 175 | 0.050 |
Why?
|
| Adult | 3 | 2025 | 31945 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 59 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 825 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 307 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 174 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2022 | 374 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2025 | 947 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 1034 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 9944 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2022 | 666 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 370 | 0.040 |
Why?
|
| Risk Factors | 1 | 2012 | 11182 | 0.030 |
Why?
|
| Aggression | 1 | 2019 | 232 | 0.030 |
Why?
|
| United States | 1 | 2012 | 11763 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2022 | 979 | 0.030 |
Why?
|
| Middle Aged | 2 | 2014 | 29399 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1506 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 2050 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 156 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 367 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 793 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1126 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3434 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1880 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 36557 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3224 | 0.010 |
Why?
|